Hunt for yield gives PE-backed firms funding avenue in Oz
Healthscope is the latest private equity-backed company to benefit from investor demand for higher-yielding debt in Australia, which may lead to savings for more of these companies in the coming months.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts